|Home | About | Journals | Submit | Contact Us | Français|
Conceived and designed the experiments: KDH LFL MB REG QM DCR SD SEB. Performed the experiments: MB QM. Analyzed the data: KDH LFL MB REG QM FLG DCR SD SEB. Contributed reagents/materials/analysis tools: JR EI. Wrote the paper: KDH LFL SD SEB.
Alternative mRNA splicing adds a layer of regulation to the expression of thousands of genes in Drosophila melanogaster. Not all alternative splicing results in functional protein; it can also yield mRNA isoforms with premature stop codons that are degraded by the nonsense-mediated mRNA decay (NMD) pathway. This coupling of alternative splicing and NMD provides a mechanism for gene regulation that is highly conserved in mammals. NMD is also active in Drosophila, but its effect on the repertoire of alternative splice forms has been unknown, as has the mechanism by which it recognizes targets. Here, we have employed a custom splicing-sensitive microarray to globally measure the effect of alternative mRNA processing and NMD on Drosophila gene expression. We have developed a new algorithm to infer the expression change of each mRNA isoform of a gene based on the microarray measurements. This method is of general utility for interpreting splicing-sensitive microarrays and high-throughput sequence data. Using this approach, we have identified a high-confidence set of 45 genes where NMD has a differential effect on distinct alternative isoforms, including numerous RNA–binding and ribosomal proteins. Coupled alternative splicing and NMD decrease expression of these genes, which may in turn have a downstream effect on expression of other genes. The NMD–affected genes are enriched for roles in translation and mitosis, perhaps underlying the previously observed role of NMD factors in cell cycle progression. Our results have general implications for understanding the NMD mechanism in fly. Most notably, we found that the NMD–target mRNAs had significantly longer 3′ untranslated regions (UTRs) than the nontarget isoforms of the same genes, supporting a role for 3′ UTR length in the recognition of NMD targets in fly.
A gene can be processed into multiple mRNAs through alternative splicing. Alternative splicing increases the number of proteins encoded by the genome, but not all alternative mRNAs produce protein. Instead, some are degraded by nonsense-mediated mRNA decay (NMD), a surveillance system that was originally identified as a means of clearing the cell of mRNAs with nonsense, or stop codon, mutations. Alternative splicing that introduces early stop codons will lead to NMD, offering a way for the cell to down-regulate gene expression after a gene has been transcribed. In this paper, we have developed a new analysis method to study the combined effect of alternative splicing and degradation in the fruit fly Drosophila melanogaster using microarrays. We have found a stringently defined set of 45 genes that can be spliced either into an mRNA that encodes a protein or into an mRNA that is degraded by NMD, down-regulating the overall gene expression. The affected genes include a number that are central to the cell's regulatory processes, including translation, RNA splicing, and cell cycle progression. Our results also help shed light on how NMD determines whether a stop codon is premature, and thus whether to target an mRNA for degradation.
Nonsense-mediated mRNA decay (NMD) is an RNA surveillance system that down-regulates mRNAs containing early stop codons in all eukaryotes examined . NMD functions to clear the cell of transcripts containing potentially harmful nonsense mutations . In addition to this role in surveillance of mutations, NMD affects the expression of numerous non-mutant endogenous targets –. These natural targets include many mRNAs that are the products of alternative splicing; one study reported that 45% of alternatively spliced human genes have at least one isoform that may be degraded by NMD .
In some of these cases, alternative splicing and NMD act together to regulate gene expression, providing an additional layer of post-transcriptional regulation. By altering the abundance and activity of splicing factors, the cell can differentially splice a pre-mRNA into a productive mRNA that encodes a protein or into an unproductive mRNA with an early stop codon that makes the mRNA a target for NMD. Unproductive splicing is used in the regulation and autoregulation of numerous genes  including mammalian splicing factors, spliceosome components – and the spermidine/spermine N1-acetyltransferase (SSAT) gene .
Alternative splicing is prevalent in the fruit fly Drosophila. At least 46% of detected genes show differential expression of alternative regions during development . In flies, alternative splicing plays an important role in many processes including sex determination, neuronal wiring, and eye development –. Although NMD is active in Drosophila, our understanding of its impact on the fly transcriptome is limited. A study of the effect of NMD on gene expression in Drosophila showed that levels of 14% of detected genes increased at least 1.5-fold after a key NMD factor, UPF1, was depleted . This analysis used gene expression microarrays that assess total mRNA from a gene, and thus it could not measure the levels of distinct alternative splice forms. Natural NMD targets produced by alternative splicing in Drosophila have not been assayed previously.
The NMD machinery of Drosophila, as in all eukaryotes studied, requires the core set of UPF proteins, UPF1, UPF2, and UPF3 ,. As in mammals, it also involves SMG1, SMG5, and SMG6 (but, unlike mammals, not SMG7), which are involved in the phosphorylation and dephosphorylation of UPF1 . Although the core NMD machinery is essentially the same in human and Drosophila, the mechanism by which premature termination codons are recognized is different in the two organisms. In both cases, the nonsense codon seems to be recognized as premature based on its position relative to proteins associated with the transcript, downstream of the stop codon. In human, the primary downstream markers are exon junction complexes deposited during splicing ,. Exon junction complexes are not required for NMD in Drosophila . A recent study indicates that, instead, some early stop codons are recognized based on their distance from the poly-A tail, mediated by the binding of cytoplasmic poly-A binding protein (PABPC1) . This study provided valuable data about the NMD mechanism based on manipulation of a single reporter construct. Studies of a wider range of NMD targets are necessary before a general rule can be inferred.
Splicing-sensitive microarrays have been used successfully to assay alternative splicing on a global scale (reviewed in ). This method has been applied in fly to assess global splicing changes when splicing factors are inhibited or overexpressed and to measure sexually dimorphic splicing –. Microarrays have also been used to measure the effect of NMD on the levels of alternatively spliced mRNAs in human, mouse, worm, and yeast ,,,. However, most techniques used to analyze these microarrays only measure the change in probes specific to individual alternative splice junctions or alternative exons. One method, successfully used to assay alternative splicing in human, measures changes in exon inclusion events , but has yet to be extended to more general splicing events. None of these methods provide isoform-level fold-changes, limiting their ability to find NMD targets. In this work, we have developed a new algorithm that makes it possible to obtain isoform-level measurements for all categories of alternative splicing and alternative processing events. We use a generative non-linear regression model to deconvolve individual probe measurements into estimates of overall isoform-level fold-changes and relative proportions of isoforms.
Our goals in this project were two-fold: first, to determine the effect of NMD on alternatively spliced mRNAs in the Drosophila transcriptome, and second, to identify features of these transcripts that might cause them to be targets of NMD. To assess the effect of NMD, we have inhibited NMD in Drosophila cells and measured changes in expression on a custom splicing-sensitive microarray. After measuring junction and exon splicing changes and then estimating isoform-level fold-changes, we identified NMD targets using a hierarchy of stringent criteria that eliminate many secondary effects and potential artifacts, at the cost of substantially reduced sensitivity to legitimate NMD targets. Using this conservative approach, we have found a high-confidence set of 45 genes where NMD decreases the level of one isoform without impacting the levels of other isoforms. We found that the reading frames of NMD–target mRNAs were often misannotated in sequence databases. After identifying the correct reading frames, we found that the NMD–target mRNAs differed significantly from the nontarget isoforms, with shorter coding regions and longer 3′ untranslated regions (UTRs). Our results show that alternative splicing and NMD affect a diverse set of genes in fly including genes involved in translation and mitosis, suggesting that regulation of unproductive splicing might play important roles in Drosophila.
We previously developed a splicing-sensitive microarray to detect alternative splicing, alternative transcription start sites, and alternative polyadenylation in Drosophila . The array contains 43,337 exon and junction probes, targeting 7,768 transcripts of 2,793 alternatively processed genes in FlyBase 4. In order to identify cellular mRNAs naturally targeted by the NMD machinery, RNA was obtained from a previous experiment in which levels of the key NMD effectors UPF1 and UPF2 were reduced in S2 cells by dsRNAi, with three independent knockdowns of each effector . Following the functional knockdown of the NMD machinery, confirmed by the stabilization of an NMD reporter, RNA was extracted and the microarray was used to probe the changes in alternative splicing patterns relative to the patterns in control cells treated with an unrelated dsRNA.
When compared with the control samples, the upf1 knockdown samples showed substantial probe-level changes, as well as substantial down-regulation of probes targeting upf1 (Figures S1, S2, S3, S4). The upf2 knockdown showed smaller probe-level changes, and we observed that the probes to the upf2 gene itself showed only a small decrease in the upf2 knockdown compared to control, with the exception of one highly up-regulated probe targeting the same area as the dsRNA. This indicates that the upf2 knockdown was less effective. We have therefore excluded the upf2 results from our primary analysis; further data are available in the Supplementary Results in Text S1.
Splicing-sensitive arrays that contain splice junction probes can easily measure the change in the use of a given splice junction. However, to study the effect of NMD on mRNA stability, we must know the fold-change of the entire set of isoforms, which may include multiple alternatively spliced junctions. This is not trivial because many of the probes on the array target multiple transcripts. We have developed a new algorithm, based on a generative non-linear regression model with least squares estimation, to deconvolve the measurements of multiple probes targeting different combinations of isoforms into an overall fold-change measurement for each isoform. In addition to isoform fold-changes, the algorithm yields estimates of the relative proportions of the different isoforms.
Deconvolution requires probes targeting different combinations of isoforms. For a gene with only two isoforms, we require probes targeting the two individual isoforms as well as probes targeting both isoforms; having only probes targeting the individual isoforms would preclude the estimation of relative abundance. As an example of a situation where deconvolution is impossible, alternative polyadenylation can produce two isoforms that differ only in the length of the last exon, and there is no possible probe that uniquely targets the shorter isoform. For genes with more than two isoforms the details are more subtle, but in general a gene with isoforms requires probes targeting at least different combinations. This requirement makes it difficult to deconvolve genes with many isoforms, and, in some cases, it is provably impossible to obtain isoform-level fold-changes. Also, the algorithm and the array design assume that gene structures are known. Unknown alternative splice forms may lead to misinterpretation of the observed probe fold-changes. Examples of gene structures, probe locations, probe and isoform fold-changes, and relative proportions can be found in Figure 1.
The mathematical formulation of the generative model is presented in the Materials and Methods section. The algorithm should be of general use in integrating data from splicing-sensitive microarrays to infer isoform-level changes. The principles behind the algorithm can also be applied to other methods such as high-throughput mRNA sequencing for studying alternative splicing.
Using the algorithm, we were able to deconvolve the isoform-level fold-changes in the upf1-knockdown experiment for 1,410 of 1,576 genes with two isoforms and for 668 of 1,124 genes with three or more isoforms (involving as many as 11 isoforms). 574 of the genes were not deconvolved because they did not satisfy the requirement of having different probe combinations. The generative model imposes certain restrictions on the fold-change of a probe targeting multiple isoforms; 38 genes grossly violating these restrictions were flagged as inconsistent and no predictions were made for these genes.
Following deconvolution, we used statistical tests to classify the isoform-level changes. In microarray measurements, it is difficult to distinguish mRNAs whose levels do not change between conditions from mRNAs that are not present in either condition. For our study, we are most interested in cases where one isoform is differentially affected by NMD inhibition. An overall change in gene expression, with no change in splicing, can appear to be differential abundance of isoforms if one isoform is never present and is incorrectly called “unchanged.” To eliminate these false positives we devised a heuristic method to call isoforms “possibly absent,” at the expense of incorrectly eliminating some unchanged isoforms. The heuristic method is based on the reasoning that an mRNA should have positive evidence for its presence; in the absence of positive evidence we would rather conservatively conclude the transcript is absent than that it is present and unchanged. The “possibly absent” isoforms were excluded from later analyses, greatly improving the reliability of identified NMD–affected genes.
Using a cutoff of 0.001, we found that 1,553 genes out of the 2,078 deconvolved genes show no change in expression upon inhibition of NMD. The remaining 525 genes have a total of 1,384 isoforms, of which 285 were “up-regulated,” 287 “slightly down-regulated,” 41 “very down-regulated,” 58 “unchanged,” and 713 were classified as “possibly absent.”
In order to identify genes with isoforms targeted by NMD, we considered the joint behavior of all isoforms of the gene. To generate a high-confidence set of affected genes, we focused on high specificity with a consequent reduction in sensitivity. Therefore, our results do not provide an estimate of the prevalence of unproductive splicing, as many true NMD targets will be excluded by our criteria. To avoid making predictions based on secondary effects of the knockdown, we used the following reasoning:
Using this classification scheme, a two-isoform gene is called an NMD target if the more abundant isoform is unchanged and the less abundant isoform is up-regulated upon NMD inhibition. As a result, this scheme primarily identifies NMD–affected genes that do not show gene-level differential expression, excluding most genes with a change in transcription level. For genes with more than two isoforms, we required that at least one isoform be up-regulated, at least one isoform be unchanged or only slightly down-regulated, and the rest of the isoforms be up-regulated, unchanged, slightly down-regulated, or possibly absent.
The full characterization of a gene as affected by NMD involves a number of sequential statistical tests. Correcting for multiple testing in a situation with nested tests is an open problem in statistics. We approach this problem by generating two sets of genes affected by NMD: one highest-confidence set where all significance levels were fixed at 0.001 (stringent) and one set where all levels were fixed at 0.05 (less stringent).
Our analysis of the upf1 knockdown revealed 45 genes putatively affected by NMD with the stringent threshold (Table 1) and 189 genes putatively affected by NMD with the less stringent threshold (Tables S5, S6, S7, S8, S9, S10, S11, S12). We will focus on the stringent set throughout our analysis.
We performed a Gene Ontology (GO) term enrichment analysis with the program AmiGO on the set of 45 affected genes to assess the effect of alternative splicing and NMD on cellular processes (Table 2, Tables S3, S4) . The most significantly enriched biological process term, when comparing the NMD–target genes to all genes represented on our array, was “translation” (, with no multiple testing correction), and parents of this term were also enriched. The NMD–target genes in this category encode five ribosomal proteins and two other RNA-binding proteins with roles in translation. The NMD–target genes also include another five genes encoding RNA-binding or splicing-related proteins, but related GO terms were not significantly enriched (). Terms related to the mitotic spindle were also enriched (e.g., for “mitotic spindle elongation”). Interestingly, ribosomal protein genes were also largely responsible for this enrichment; many ribosomal proteins were previously identified in a genome-wide screen for mitotic spindle defects .
It was previously observed that knockdown of upf1 or upf2 caused cell cycle arrest in the G2/M phase . To further investigate the connection between mitosis and NMD, we compared our set of NMD–affected genes to sets of genes associated with mitosis. Amongst our NMD targets, there was a significant enrichment () of a set of 402 genes with known mitotic defect phenotypes (119 of which were alternatively spliced and thus measured on our array) ,. The overlap comprised six genes, including the five genes with mitotic spindle GO annotations found in our AmiGO analysis. However, there was no enrichment of a set of 1000 genes that are co-expressed with known mitotic genes and likely to be differentially expressed in mitosis . We believe it is unlikely that the mRNAs identified in our analysis as NMD targets are, instead, predominantly secondary effects of mitotic arrest, although we do not rule out the possibility that a subset of putative NMD targets actually represent such secondary effects. Indeed, the AmiGO results suggest that unproductive splicing of the six ribosomal and RNA-binding proteins may play a more direct role in cell cycle progression.
We experimentally tested the NMD status of isoforms of 10 genes chosen for having a large fold-change in at least one junction probe after upf1 inhibition. Four of these genes had been called NMD–affected based on the microarray deconvolution, four genes had been called unaffected, and two genes had complex splicing patterns that had prevented their deconvolution. We used RT-PCR to measure the effect of upf1 and upf2 knockdowns on the 10 genes (Figure 2 and Figures S7, S8). We saw that the ratio of NMD–targetnontarget mRNA increased upon upf1 and upf2 knockdown for all four genes called NMD–affected, confirming the array analysis. For three of the four genes called unaffected, we also confirmed the array analysis. One gene, CG8046, was called unaffected based on the array data, but RT-PCR showed that it is probably an NMD target because the ratio of isoform BA increases substantially upon NMD inhibition. Finally, two genes could not be deconvolved in the array analysis but have large individual probe fold-changes. Both genes, RpS9 and RpL3, are shown by RT-PCR to have an NMD–target isoform (Figure S7). In all, we found that the array analysis properly classified all isoforms of 7 out of 8 genes it was able to deconvolve. The analysis had no false positives, but as expected our analysis sometimes missed true NMD targets.
Our results complement those of a previous study that identified NMD targets in Drosophila using a microarray approach that did not distinguish between alternative splice forms. Rehwinkel et al. used a gene expression microarray to measure the effect of inhibiting each of six NMD effectors . They found that 525 mRNAs, or 14.3% of genes detected on the array, were up-regulated at least 1.5-fold after depleting UPF1. They focused on a core group of 184 genes that were up-regulated in at least 10 of their 12 knockdowns.
For each gene on our array, we compared the fold-change from the Rehwinkel et al. upf1 knockdown with the gene-level fold-change from our analysis, obtained by averaging constitutive probes (Figures S5, S6). The two experiments have a correlation of 0.6.
As described above, our classification scheme focuses on genes that generally do not show differential expression at the gene level. For that reason, we would not expect a strong concordance between the NMD–affected genes identified in the two studies. Also, we only assayed genes annotated with multiple isoforms, which are only a small subset of the genes present on the Rehwinkel et al. platform. Indeed, there is almost no overlap between the two sets of inferred NMD targets; the only genes that were found to be affected by NMD in both studies are CG13900, CG10948, and glorund, all three involved in RNA processing.
Rehwinkel et al. validated the direct effect of NMD on nine genes, three of which were present on our array. One of these, CG13900, is an NMD target in our set. The other two genes are not classified as NMD targets in our results because they showed a change in overall expression rather than a differential effect on different isoforms. Rehwinkel's validation also demonstrated that two genes in their core set of NMD–affected genes, pgi and CG30035, do not appear to be direct NMD targets. Both genes were present on our array and both were correctly called nontargets.
Although the exact mechanism of premature stop codon recognition is unknown in Drosophila, it is generally assumed that NMD–target mRNAs have early stop codons relative to nontarget mRNAs. In light of this, it was startling that 35 of 45 genes in the set of NMD affected genes were annotated in FlyBase with the same stop codon in the NMD–target and nontarget isoforms. We determined that the annotated FlyBase coding sequence (CDS) was often unlikely to be the biologically accurate CDS. The FlyBase annotation protocol automatically chooses the longest open reading frame (ORF) of each transcript as the CDS, unless other evidence is available . For the thousands of alternatively spliced genes, this annotation strategy may introduce substantial misinformation into gene and protein databases.
To understand the effect of NMD on a transcript, we identified the reading frame most likely to be recognized by the ribosome. In general, a eukaryotic ribosome initiates translation at the 5′-most AUG of an mRNA . However, the ribosome may skip one or more AUG codons before initiating translation, or it may first translate a short upstream ORF (uORF) . No single strategy for annotating reading frames will correctly represent the biology in all cases. We were guided by the principles that a gene should have at least one transcript that encodes a full-length, functional protein, and that the start codon of that transcript is likely to be recognized in the other, alternative transcripts as well.
We employed two distinct methods to choose the correct CDS. One method makes use of the upf1 knockdown data to help identify the transcript most likely to encode a full-length, functional protein. We assumed that in most cases this transcript would not be a target of NMD. Therefore, we chose the longest ORF found in any NMD nontarget isoforms of a given gene as the canonical CDS. We then assumed that the start of this canonical CDS is recognized in vivo, regardless of whether it begins at the first AUG codon in the transcript. We inferred the CDS of each isoform by choosing the ORF beginning at this canonical start codon (Figure 3). In some isoforms, alternative processing has introduced isoform-specific sequence upstream of the canonical start codon, e.g., due to an upstream promoter or alternative splicing in the first intron (Figure 3B). In these cases, we considered the possibility that the alternative sequence contains a new, upstream AUG that is recognized by the ribosome, perhaps as the start of a short uORF with an early stop codon.
The second method to annotate CDSs is blind to NMD status. The longest ORF present in any transcript, NMD–target or nontarget, was chosen as the canonical CDS, and its start codon was used to annotate the CDS in all transcripts. This second method has the benefit of being unbiased, but because it ignores some data, it is likely to be less accurate. The results from this second, unbiased method were used in our statistical analysis of gene features correlated with NMD status. Full details of our reannotation methods are found in the Supplementary Methods in Text S1.
Basing the CDS annotation on the NMD status of each transcript in the set of 45 upf1-affected genes, the first annotation algorithm found 27 genes with a noticeably early stop codon in the NMD–target isoform relative to the nontarget isoform, out of 41 genes (four genes were removed from the analysis because of inconsistencies between FlyBase 4 and more recent transcript data). Without using NMD status as input, the second annotation algorithm found early stop codons in 23 out of 41 genes. The NMD–affected isoforms without early stop codons may represent unknown aspects of the NMD mechanism or, more likely, secondary effects of the knockdowns. We also re-annotated the CDS of the upf1-affected genes identified with the less stringent cutoff. Early stop codons are found in a lower percent of the NMD targets in this set compared to the strict set: 92/181 using NMD status, and 65/181 without using NMD status. This suggests that the less stringent may include more genes that are not directly affected by NMD.
If the NMD–target mRNAs do not encode functional proteins, we would not expect their CDSs to be optimized for translation efficiency or under selective pressure to maintain amino acid sequence. A comparison to overall Drosophila codon usage showed that the nontarget mRNAs were significantly skewed towards preferred codons and the NMD–target mRNAs showed less preference for preferred codons. This indicates that the unproductive reading frames are less optimized for translation efficiency. We also estimated the ratio of non-synonymous to synonymous substitutions (dN/dS) in dual-coding regions in which the reading frame of the NMD–target isoform is shifted relative to the nontarget isoform, comparing D. melanogaster to D. ananassae using PAL2NAL  (Supplementary Results in Text S1). In 3 of 4 dual-coding regions, from glo, robo, and CG4452, the NMD–target reading frame had a very high dN/dS, indicating that it was probably not under coding sequence constraints, and the nontarget reading frame had a low dN/dS as expected. In only one gene, CG9413, dN/dS was lower in the NMD–target reading frame than in the nontarget reading frame, indicating that this sequence might be under protein-coding constraints in both frames. Overall, these results suggest that our CDS annotation was generally accurate, and support the notion that our NMD–target mRNAs do not yield protein.
We sought to find features of mRNAs that were correlated with NMD target status. These features could reveal aspects of the NMD mechanism for recognizing premature stop codons. We considered the lengths of the 5′ UTR, 3′ UTR, and CDS; the number of introns in the UTRs, the CDS, and the transcript as a whole; the number and size of potential uORFs; and sequence features such as A-rich regions. These features were chosen based on existing hypotheses about NMD. The presence of introns in the 3′ UTR triggers NMD in human, while the length of the 3′ UTR has been implicated in NMD in Drosophila . Small upstream ORFs might trigger NMD of some transcripts , and A-rich elements in mammalian 5′ UTRs also destabilize some mRNAs via the binding of PABPC1 . Although experiments have shown that NMD of a reporter construct in Drosophila does not depend on components of the exon junction complex , we also tested the possibility of a rule akin to the human 50-nucleotide rule. We computed the distance between the stop codon and the position of the last exon junction in the transcript.
The NMD targets and NMD nontargets were first compared using an unpaired analysis, where we compare the marginal feature distributions for each of the two sets of isoforms (Figure 4A). Such a comparison yielded little difference between the two groups, mostly due to high heterogeneity between genes relative to differences between distinct isoforms of the same gene. We therefore proceeded with a more powerful paired analysis in which we compared each feature of the NMD–target isoform with the corresponding feature of the NMD nontarget isoform for the same gene. In case a gene has two or more isoforms that are labeled target or nontarget, the feature values for the isoforms of the given gene were averaged to yield a single number per gene per category. For each comparison we considered both one- and two-sided tests with the alternative hypothesis that the NMD–target isoforms have, for instance, longer 3′ UTRs or more introns in the 3′ UTR region.
We found six features to be correlated with NMD status in the upf1-affected genes (Figure 4 and Figures S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21). Relative to the nontarget isoforms, the NMD–target isoforms have shorter CDSs, fewer introns in the CDS, longer 3′ UTRs, more introns in the 3′ UTR, longer ORFs in the 3′ UTR, and a greater distance between the stop codon and the last intron. All of these features were significant at a 5% level with between 0.0008 and 0.003 (one-sided tests; for two-sided tests were twice as large) for the stringent set of upf1-affected genes. All six features had somewhat less significant using the less stringent set of targets (between 0.042 and 0.09 for one-sided tests).
In our set of NMD–affected genes we find that there are essentially two subgroups. One subgroup of genes shows the differences described above, with longer 3′ UTRs in NMD–target mRNAs. In the other group, the NMD target and nontarget isoforms of a given gene share the same 3′ UTR structure – implying that no feature in the 3′ part of the gene can be responsible for NMD recognition. Some of these genes might have been classified incorrectly and may instead reflect secondary effects of NMD inhibition.
We also used MEME to search for overrepresented sequence motifs within the 3′ UTRs of NMD–target mRNAs , analogous to the downstream element implicated in NMD in yeast . The only motifs found to be enriched within the UTRs of NMD–target mRNAs were repetitive sequences (Figure S22A). When we limited the search to the UTRs of NMD–target mRNAs with early stop codons, we found two additional non-repetitive motifs (Figure S22A), but both are similar to known splicing enhancers . No significant motifs were found in the UTRs of the nontarget mRNAs.
The features correlated with NMD status are obviously not independent, and our data cannot resolve which, if any, of these are detected directly by the NMD mechanism. Alternative splicing has only a small effect on the length of the mRNAs produced from most of the NMD–affected genes; its principal effect is to change the position of the stop codon, simultaneously shortening the CDS and lengthening the 3′ UTR. The change in 3′ UTR length may also account for the significance of the other features that distinguish NMD–target from nontarget isoforms.
Our observation of longer 3′ UTRs agrees with previous work indicating that the NMD mechanism in Drosophila is affected by the length of the 3′ UTR. Behm-Ansmant et al. determined that nonsense codons in an adh reporter construct are recognized as premature based on the distance between the stop codon and PABPC1 bound to the poly-A tail of the transcript . Stop codons 379 nucleotides or fewer upstream of the poly-A tail did not elicit NMD, but stop codons 397 nt or more upstream of the poly-A tail caused degradation. Our larger set of natural NMD targets allows us to compare this length to the UTR lengths of the transcripts identified by our array to see if that result is more generally applicable.
We found that on average the NMD–target isoforms have longer 3′ UTRs than the nontarget isoforms, but 397 nt is not a discriminant. Almost all (33/41) of the NMD–target isoforms have UTRs longer than 397 nt, but over a third (17/44) of the nontarget isoforms also have UTRs longer than 397 nt. It may be more appropriate to include only genes that are more likely to be direct NMD targets. The 397 nt cutoff does describe all but one of the 27 NMD–target isoforms with an early stop codon relative to the non-target isoform of the same gene. However, 9 of 28 nontarget isoforms also have a 3′ UTR longer than 397 nt. From our data, the best descriptor seems to be a length cutoff of 742 nt, which correctly classifies 26/27 NMD–target mRNAs and 22/28 nontarget mRNAs. It is clear that the length of the 3′ UTR is a key determinant of NMD, but neither our statistical correlation nor the published experimental study provide a general rule for predicting NMD status.
We have found that alternative splicing in Drosophila can produce mRNAs that are targets of NMD. Using strict criteria, we find 45 genes with both an isoform that is stabilized after NMD inhibition and an isoform that is not affected by NMD inhibition. Our set includes examples of many different modes of alternative processing, including cassette exon skipping or inclusion, alternative 5′ or 3′ splice sites, intron retention, and alternative splicing combined with alternative transcription start sites or polyadenylation. Note that our conservative criteria are not intended to provide a full measure of the true prevalence of unproductive splicing in fly.
Most of the NMD–target isoforms have early stop codons relative to the unaffected isoform of the same gene, indicating that our results include many direct targets of NMD. However, a third of the apparent NMD–target isoforms in the stringent set do not have early stop codons. While some may be false positives, others are likely to represent secondary effects of NMD inhibition, genes with unannotated alternative splicing events, or unknown aspects of the NMD pathway. The NMD machinery may recognize and degrade some mRNAs whose stop codons do not appear premature, as occurs in the mammalian UPF1-dependent process known as Staufen mediated decay ,.
Many NMD–affected genes without early stop codons may not be direct targets of NMD and may instead demonstrate the downstream effects of unproductive splicing. Secondary splicing effects are particularly likely in cases when splicing factors are direct targets of NMD. In C. elegans, the altered expression of splicing factors after NMD inhibition may affect the splicing of numerous genes . Our set of NMD–affected genes includes at least seven genes encoding characterized RNA-binding or splicing-related proteins. One of these splicing factors, Squid, is known to affect the splicing of at least 255 other genes . Among its targets are five genes identified as NMD–affected in this study, and one of these genes has no early stop codon. There may be additional splicing factors affected by NMD which our methods overlooked. Alternative isoforms of the SR splicing factor B52 were dramatically stabilized upon NMD inhibition, but this gene was not classified as an NMD target because we could not determine if the nontarget isoforms were present. Ten NMD–affected genes in our results are known targets of B52, three of which have no early stop codon ,. Our set of targets also includes at least two transcription factors, Dll and FTZ-F1, and altered transcription may thus be a secondary effect of inhibiting NMD. Further, upf1 and upf2 knockdowns cause cell cycle arrest in mitosis , which may cause secondary splicing effects and confound our interpretation of NMD targets. However, the six known mitosis-related genes amongst our targets almost all have early stop codons and thus appear likely to be direct NMD targets. This leads to the intriguing possibility that the mitotic arrest phenotype is due to the misregulation of specific unproductive splicing events after NMD inhibition.
NMD was initially identified for its role in clearing the cell of erroneous and potentially harmful mRNAs. However, unproductive splicing can also be used to regulate gene expression. In mammalian systems, alternative splicing and NMD are combined to regulate the expression of numerous genes. RNA-binding proteins and ribosomal proteins, in particular, seem to employ unproductive splicing to autoregulate their expression, perhaps to maintain homeostasis (,,,; reviewed in ). We have shown that this theme is continued in Drosophila. Many translation and splicing-related proteins are found in our set of fly NMD targets, and further investigation may elucidate important roles of unproductive splicing in the regulation of Drosophila processes.
RNA interference was performed against upf1 and upf2 and RNA was obtained from cultured Drosophila Schneider cells as described in . As a reference, RNA was obtained from mock-treated cells as in . Samples from three independent knockdowns of upf1 and upf2 were amplified, labeled, and hybridized onto a custom two-color microarray as described in .
Reverse transcription and amplification were performed as described in . For each experiment, 1 µg of RNA was reverse transcribed using SuperScript II (Invitrogen) following the manufacturer's protocol. One-fiftieth of the RT reaction was used in a PCR reaction with Taq polymerase (NEB) following the manufacturer's protocol. PCR primers were chosen to flank the alternatively spliced region and the primer sequences are available upon request.
The microarray was manufactured by Agilent using the 44 k platform with a custom array design. The array was designed using the methods described in , but updated to use data from FlyBase 4.0. The updated array design had two improvements: the exonic probes were chosen to be isothermal with the average of the junction probes, and a 20-nt dT stilt was added to decrease the chance of steric hindrance between the labeled probes and the glass surface. The 43,337 probes on the array (excluding control probes) measure the following target sequences: 10,694 alternative exons or splice junctions, 25,213 constitutive exons or splice junctions, 2,798 alternative polyadenylation events, and 4,632 alternative transcription start events. In addition, there are 10 negative controls and 23 positive controls. In total, the array interrogates 7,768 transcripts of 2,793 genes.
The image analysis was performed by Agilent Feature Extraction version 7.5.1. The scanned images were preprocessed using the limma package  from Bioconductor release 2.1 . The background correction was done using the normexp method , with an offset of 10, and was followed by loess normalization between the red and the green channel within each array. Raw and preprocessed data have been submitted to GEO with accession number GSE13532.
As a motivating example we start by considering the behavior of a probe targeting two different isoforms of the same gene (for example, an exon probe for a constitutively expressed exon). Let and be the absolute amounts of mRNA of isoforms 1 and 2 in the control sample and let and be the absolute amounts of mRNA of isoforms 1 and 2 in the treatment sample. The treatment-control fold-change for the probe is then
with , , . We recognize and as the fold-changes associated with isoforms 1 and 2 and as the relative proportion of isoform 1 in the control sample. These relative expression parameters are estimable from a microarray experiment, as opposed to the absolute mRNA amounts.
This approach can be immediately generalized to a probe targeting out of isoforms of a given gene. In this case, the treatment-control fold-change associated with such a probe becomes
with being the fold-change associated with the isoform and being the relative proportion of isoform out of all isoforms.
Because noise in microarray experiments appears to be additive on the log scale, we propose the following model
with being the observed fold-change for probe and sample ,
being the fold-change parameter defined above, and being a noise term. is a function that for every probe yields which isoforms the probe targets.
We propose to estimate the parameters and using non-linear least squares, i.e., by solving the following minimization problem
Based on a heuristic argument, we expect the presence of the logarithm to turn this into a non-convex optimization problem.
A variant of this minimization problem, where the constraint is replaced by , is solved using an adaptive barrier method proposed by  and implemented in the R function constrOptim, using a collection of suitably chosen starting points intermixed with random points.
Hypotheses related to the differential expression parameters, such as (is isoform not differentially expressed) or (are isoforms 1 and 2 similarly expressed), are tested using F-statistics (for details see a reference on non-linear regression such as ).
For each gene, isoform-level measures were deconvolved using the approach described above, and each isoform classified according to the process depicted in Figure 5. For every isoform in the gene, the following hypotheses were tested: (is isoform not differentially expressed), , (is isoform possibly absent). Any given hypothesis was considered rejected if the nominal was lower than 0.001 (“stringent” set) or 0.05 (“less stringent” set) and accepted otherwise. An isoform was characterized as “up-regulated” if was rejected and , “slightly down-regulated” if was rejected and , “very down-regulated” if was rejected and , “unchanged and present” if was accepted and a nested test of against was rejected, and finally as “possibly absent” if was accepted ( was not tested for this classification). With this characterization, it is possible for an isoform to be labeled as “unchanged and present” as well as “possibly absent.” In that case, “possibly absent” takes precedence.
Based on this characterization, a gene was labeled as “NMD affected” if at least one isoform was “up-regulated,” at least one isoform was “slightly down-regulated” or “unchanged and present,” and the remaining isoforms were either “slightly down-regulated,” “unchanged and present” or “possibly absent.” The isoforms for such a gene were labeled as either “NMD target,” “NMD nontarget,” or “possibly absent.” These labels were used as input in the feature correlation.
We used AmiGO  to compare the GO terms of all genes on our array vs both the strict and less-strict sets of NMD–affected genes, with a p-value cutoff of 0.01. Annotations were obtained from FlyBase via AmiGO.
For every gene that had an isoform affected by NMD, we labeled the isoforms affected by NMD as NMD targets, the isoforms present but not affected by NMD as NMD nontargets, and we discarded the isoforms that were not present.
For each feature we performed a paired as well as an unpaired analysis. The unpaired analysis compares the distribution of a feature for the NMD–target isoforms to the corresponding distribution for the NMD nontarget isoforms. The paired analysis computes, for each gene, the difference between the feature for the NMD–target isoform and the feature for the NMD nontarget isoform. The distribution of these differences are then compared to zero. In case there were two or more isoforms in a group, the values of the feature were averaged. As expected, we found the paired comparison to be more powerful.
Specifically, for every feature, we performed a Wilcoxon rank sum test with exact permutation . The test was either paired or unpaired depending on the analysis being done. The permutation were computed using the package coin, see . We also visually inspected the distributions using boxplots and scatterplots; see Figures S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21 and Tables S1, S2.
Overlayed MA plots for upf1. MA plot of the 3 normalized upf1 arrays. The three arrays have been superimposed on the same plot. The red line is a lowess line, and the blue line is M=0. The yellow/green points are probes targeting upf1/upf2 and the blue/purple points are positive (present)/negative (absent) control probes.
(0.79 MB PDF)
Overlayed MA plots for upf2. As Figure S1, but for upf2.
(0.79 MB PDF)
Individual MA plots for upf1. MA plots of the 3 normalized upf1 arrays side by side. Lines and colorscheme are as in Figure S1.
(2.28 MB PDF)
Individual MA plots for upf2. MA plots of the 3 normalized upf2 arrays side by side. Lines and colorscheme are as in Figure S1.
(2.26 MB PDF)
Smoothed scatterplot of upf1 and Affymetrix data. Smoothed scatterplot of gene level log2 fold changes from this study versus Rehwinkel et al., from the upf1 arrays. Rehwinkel's normalized data was obtained from Array Express E-MEXP-202. Genes that were labelled as absent in either study were removed. The blue line is y=x and the red line is lowess smoother. Our gene level fold changes were obtained by averaging all probes annotated as being constitutive. Using only constitutive exon probes instead of constitutive exon and junction probes did not qualitatively change the scatterplot.
(0.68 MB PDF)
Smoothed scatterplot of upf2 and Affymetrix data. As Figure S5, but for upf2.
(0.68 MB PDF)
RT-PCR shows NMD in RpS9 and RpL3. RT-PCR shows NMD-target isoforms of RpS9 and RpL3. Neither gene could be deconvolved by our array analysis.
(0.51 MB PDF)
RT-PCR validation of NMD. Full gels from the RT-PCR validation described in main Figure 1.
(1.45 MB PDF)
Length of 5′ UTR. Top right and top left plots are boxplots comparing the set of NMD-target mRNAs to the set of NMD nontarget mRNAs from the same genes, for both the stringent and the less stringent set of upf1-affected genes. Bottom right and bottom left are scatterplots between mRNAs of the same gene, labelled as either NMD-target or NMD nontarget, for both the stringent and the less stringent set of genes. The feature in question is the “length of 5′ UTR.” The scatterplots have an aspect ratio of 1.
(0.06 MB PDF)
Length of longest ORF in the 5′ UTR. As Figure S9 for the feature “length of longest ORF in 5′ UTR.” The bottom left scatterplot has been jittered.
(0.05 MB PDF)
Fraction of A nucleotides in 5′ UTR. As Figure S9 for the feature “fraction of A nucleotides in 5′ UTR.” The bottom left scatterplot has been jittered.
(0.05 MB PDF)
Length of longest A-rich region in 5′ UTR. As Figure S9 for the feature “length of longest A-rich region in 5′ UTR.” The bottom left scatterplot has been jittered.
(0.05 MB PDF)
Length of 3′ UTR. As Figure S9 for the feature “length of 3′ UTR.”
(0.05 MB PDF)
Number of introns in 3′ UTR. As Figure S9 for the feature “number of introns in 3′ UTR.” Both the bottom right and the bottom left scatterplots have been jittered.
(0.05 MB PDF)
Length of longest ORF in 3′ UTR. As Figure S9 for the feature “length of longest ORF in 2′ UTR.”
(0.05 MB PDF)
Fraction of A nucleotides in 3′ UTR. As Figure S9 for the feature “fraction of A nucleotides in 3′ UTR.”
(0.05 MB PDF)
Length of longest A-rich region in 3′ UTR. As Figure S9 for the feature “length of longest A-rich region in 3′ UTR.”
(0.05 MB PDF)
Number of introns in transcript. As Figure S9 for the feature “number of introns in transcript.” The bottom left scatterplot has been jittered.
(0.05 MB PDF)
Length of CDS. As Figure S9 for the feature “length of CDS.”
(0.05 MB PDF)
Number of introns in CDS. As Figure S9 for the feature “number of introns in CDS.” The bottom left scatterplot has been jittered.
(0.05 MB PDF)
Distance from stop codon to final intron. As Figure S9 for the feature “distance from stop codon to final intron.” CG11100 did not have any introns and is not assigned a value.
(0.05 MB PDF)
Motifs found by MEME. A. Overrepresented motifs found in the 3′ UTRs of NMD-target mRNAs. MEME was used to search for motifs with a width of 6–16 nt occurring zero or one times per sequence. All motifs appear to be repetitive sequence. B. Overrepresented motifs found in the 3′ UTRs of the 27 NMD-target mRNAs with an early stop codon. Motifs 2, 3, and 5 match the motifs in (A); motifs 1 and 4 appear similar to known RARRAR splicing enhancers.
(0.47 MB PDF)
Number of AUG (start) codons in 5′ UTR. Tables (a) and (b) show an unpaired comparison between the NMD-target mRNAs and the NMD nontarget mRNAs for the stringent and the less stringent set of upf1-affected genes, for the feature “number of AUG (start) codons in 5′ UTR.” Tables (c) and (d) show a paired comparison between the two sets of mRNAs, for the stringent and the less stringent set of genes.
(0.04 MB PDF)
Number of introns in 5′ UTR. As Table S1, but for the feature “number of introns in 5′ UTR.”
(0.03 MB PDF)
GO terms enriched in stringent upf1 set.
(0.04 MB PDF)
GO terms enriched in less stringent upf1 set.
(0.03 MB PDF)
Number of genes successfully deconvolved. The number of genes deconvolved by the analysis. “Deconvolved” indicates that the deconvolution was successful, “too few configurations” indicates the there were too few probe configurations to deconvolve the gene and “inconsistent” indicates that the gene could be deconvolved, but the estimates were inconsistent with the gene model.
(0.03 MB PDF)
upf2 target genes, stringent set. Set of NMD targets for upf2, using the stringent cutoff.
(0.04 MB PDF)
upf1 target genes, less stringent set.
(0.05 MB PDF)
upf2 target genes, less stringent set.
(0.04 MB PDF)
Deconvolution results for the stringent set of upf1 affected genes.
(0.04 MB PDF)
Deconvolution results for the less stringent set of upf1 affected genes.
(0.05 MB PDF)
Deconvolution results for the stringent set of upf2 affected genes.
(0.03 MB PDF)
Deconvolution results for the less stringent set of upf2 affected genes.
(0.04 MB PDF)
Supplementary results and methods.
(0.08 MB PDF)
We thank Angela N. Brooks for valuable discussion, including sharing pre-publication data.
The authors have declared that no competing interests exist.
This work was supported by U.S. National Institutes of Health grants R01GM071655, R01GM61987, and U01HG004271. MB was the recipient of a Human Frontier Science Program long-term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.